![]() ![]() GRAIL ended the year with accelerating consumer excitement for its Galleri test more than 4,500 health providers ordered the test in 2022, contributing to more than 60,000 tests ordered to date." Our order book is exceeding expectations and we have begun shipping instruments. "Illumina's continued focus on innovation across multiple new products, including the NovaSeq X, the most powerful, most sustainable, and most cost-effective sequencer ever developed, have been met with strong customer interest. "Our fourth quarter operating results were in line with our expectations, with ongoing traction across our product portfolio amid a challenging macroeconomic environment," said Francis deSouza, Chief Executive Officer. (Nasdaq: ILMN) today announced its financial results for the fourth quarter and fiscal year 2022, which include consolidated financial results for GRAIL. For fiscal year 2023, expect revenue to grow 7% to 10% compared to fiscal year 2022, GAAP diluted earnings per share of $0.03 to $0.28, and non-GAAP diluted earnings per share of $1.25 to $1.50.Non-GAAP diluted earnings per share of $2.12 for fiscal year 2022, compared to non-GAAP diluted earnings per share of $5.90 for fiscal year 2021, and included $(0.55) per diluted share due to an increase in tax expense from R&D capitalization requirements that were not repealed in Q4 2022 and an increase in GRAIL's non-GAAP operating loss due to a full year of consolidated results in 2022 compared to a partial year in 2021.GAAP diluted loss per share of $(28.00) for fiscal year 2022, compared to GAAP diluted earnings per share of $5.04 for fiscal year 2021, and included $(24.93) per diluted share due to goodwill impairment related to the GRAIL segment and $(0.55) per diluted share due to an increase in tax expense from R&D capitalization requirements that were not repealed in Q4 2022.Non-GAAP diluted earnings per share of $0.14 for Q4 2022, compared to non-GAAP diluted earnings per share of $0.75 for Q4 2021.GAAP diluted loss per share of $(0.89) for Q4 2022, compared to GAAP diluted earnings per share of $0.71 for Q4 2021.Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis.The University of Maryland has extraordinary faculty, research, and education expertise in Social Data Science across all of the partner colleges as well as in research centers, including SoDa and START. This program will combine the expertise of BSOS and INFO faculty members to prepare students to effectively, ethically and efficiently create high quality information products, such as datasets, visualizations, and models, about human activity and behavior. Further, effective and appropriate construction, analysis, and use of social data requires understanding social science theory and domain expertise. Social data science encompasses all elements of the data life cycle, including measure conceptualization, data gathering, management, manipulation, analysis, presentation, archiving, and re-use. ![]() ![]() The major will build expertise in the complex skills needed to create and work with information that captures aspects of human behavior. The Colleges of Information Science (INFO) and Behavioral and Social Sciences (BSOS) are pleased to offer an undergraduate major (BS) in Social Data Science (SDSC) at University of Maryland!
0 Comments
Leave a Reply. |